Denmark
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.95 B
|
Dec. 31, 2023 | USD 5.46 | 0.56% |
|
Denmark |
|
2 |
USD 2.65 B
|
Dec. 31, 2023 | USD 54.16 | -1.39% |
|
Denmark |
|
3 |
USD 2.44 B
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
4 |
USD 1.05 B
|
Dec. 31, 2023 | USD 26.62 | -0.36% |
|
Denmark |
|
5 |
USD 294.39 M
|
Dec. 31, 2023 | USD 131.57 | -1.84% |
|
Denmark |
|
6 |
USD 58.73 M
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
7 |
USD 50.74 M
|
Dec. 31, 2023 | USD 95.84 | 0.08% |
|
Denmark |
|
8 |
USD 30.34 M
|
Dec. 31, 2023 | USD 91.43 | -1.85% |
|
Denmark |
|
9 |
USD 4.58 M
|
Dec. 31, 2023 | USD 0.20 | -2.77% |
|
Denmark |
|
10 |
USD 1.82 M
|
Dec. 31, 2023 | USD 0.63 | -3.68% |
|
Denmark |
|
11 |
USD 1.66 M
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
12 |
USD 1.03 M
|
Dec. 31, 2023 | USD 1.93 | -6.19% |
|
Denmark |
|
13 |
USD 695.84 K
|
Dec. 31, 2023 | USD 2.17 | 5.88% |
|
Denmark |
|
14 |
USD 62.61 K
|
Dec. 31, 2023 | USD 3.98 | 0.01% |
|
Denmark |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 0.64 | 1.38% |
|
Denmark |
The Biotechnology company in Denmark with the highest Revenue is H. Lundbeck A/S (Copenhagen Stock Exchange: HLUN-B.CO) at USD 2.95 B.
The Biotechnology company in Denmark with the lowest Revenue is Initiator Pharma A/S (Stockholm Stock Exchange: INIT.ST) at USD 0.00.
The top 10 Biotechnology companies in Denmark by Revenue are H. Lundbeck A/S, Novozymes A/S, Genmab A/S, Bavarian Nordic A/S, Ascendis Pharma A/S, ChemoMetec A/S, Zealand Pharma A/S, Gubra A/S, BioPorto A/S and BactiQuant A/S.
The bottom 10 Biotechnology companies in Denmark by Revenue are Initiator Pharma A/S, FluoGuide A/S, ExpreS2ion Biotech Holding AB (publ), ViroGates A/S, Saniona AB (publ), BactiQuant A/S, BioPorto A/S, Gubra A/S, Zealand Pharma A/S and ChemoMetec A/S.